SageView Advisory Group LLC Invests $238,000 in Axon Enterprise, Inc. (NASDAQ:AXON)

SageView Advisory Group LLC acquired a new stake in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) during the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 401 shares of the biotechnology company’s stock, valued at approximately $238,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Asset Dedication LLC lifted its holdings in shares of Axon Enterprise by 11.3% in the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock valued at $106,000 after purchasing an additional 18 shares in the last quarter. Bleakley Financial Group LLC raised its position in Axon Enterprise by 1.3% in the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock valued at $908,000 after buying an additional 20 shares during the last quarter. Venturi Wealth Management LLC lifted its stake in Axon Enterprise by 2.7% in the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock valued at $477,000 after acquiring an additional 21 shares in the last quarter. Burns Matteson Capital Management LLC boosted its position in Axon Enterprise by 3.4% during the 4th quarter. Burns Matteson Capital Management LLC now owns 757 shares of the biotechnology company’s stock worth $450,000 after acquiring an additional 25 shares during the last quarter. Finally, Transcend Capital Advisors LLC grew its stake in shares of Axon Enterprise by 3.6% during the 4th quarter. Transcend Capital Advisors LLC now owns 726 shares of the biotechnology company’s stock worth $431,000 after acquiring an additional 25 shares in the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Jeri Williams sold 307 shares of the firm’s stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the completion of the sale, the director now owns 1,627 shares in the company, valued at approximately $899,275.44. This trade represents a 15.87 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Company insiders own 6.10% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the stock. Barclays restated a “hold” rating on shares of Axon Enterprise in a report on Monday, March 10th. Needham & Company LLC restated a “buy” rating and set a $600.00 price objective on shares of Axon Enterprise in a research note on Wednesday, February 26th. Craig Hallum downgraded Axon Enterprise from a “buy” rating to a “cautious” rating in a research report on Monday, March 10th. JMP Securities reissued an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 4th. Finally, Northcoast Research downgraded Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. One analyst has rated the stock with a sell rating, two have issued a hold rating and ten have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $626.45.

Get Our Latest Research Report on AXON

Axon Enterprise Stock Performance

Shares of NASDAQ AXON opened at $571.85 on Thursday. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The stock has a 50 day moving average of $560.83 and a 200-day moving average of $563.13. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $43.82 billion, a P/E ratio of 147.77, a P/E/G ratio of 5.17 and a beta of 1.13.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Read More

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.